| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |


From the Schistosomiasis Immunology and Pathology
Unit*
and the Immunobiology
Section,
Laboratory of Parasitic Diseases,
National Institute of Allergy and Infectious Diseases, National
Institutes of Health, Bethesda; and The Biomedical Research
Institute
, Rockville, Maryland
Mice sensitized with Schistosoma
mansoni eggs and IL-12 develop liver
granulomas, on subsequent infection, which are smaller
and less fibrotic than those in nonsensitized mice. The protective
response is accompanied by a shift in the type-2 cytokine profile to
one dominated by type-1 cytokines. The deviated response is associated
with marked increases in inducible nitric oxide synthase (NOS-2)
activity. Here, we demonstrate, by using
NOS-2-deficient mice, that the anti-inflammatory and
anti-fibrotic effects of the type-1 response are completely
NOS-2-dependent. Strikingly, despite developing a polarized
type-1 cytokine response that was similar in magnitude, the
egg/IL-12-sensitized NOS-deficient mice developed granulomas 8 times
larger than WT mice did. There was also no decrease in hepatic fibrosis
in the sensitized mutant animals. Interferon-
-deficient mice failed
to exhibit the exacerbated inflammatory response, despite
displaying a marked deficiency in nitric oxide production.
However, immune deviation was unsuccessful in the latter
animals, which suggested that the increase in inflammation in
NOS-deficient mice resulted from a polarized but nitric oxide-deficient
type-1 response. These results reveal a beneficial role for NOS-2 in
the regulation of inflammation and suggest that the ultimate success of
Th2-to-Th1 immune deviation strategies will rely on the efficient
activation of NOS-2 expression in downstream effector
cells.
This article has been cited by other articles:
![]() |
Z. T. Kelleher, A. Matsumoto, J. S. Stamler, and H. E. Marshall NOS2 Regulation of NF-{kappa}B by S-Nitrosylation of p65 J. Biol. Chem., October 19, 2007; 282(42): 30667 - 30672. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Leeto, D. R. Herbert, R. Marillier, A. Schwegmann, L. Fick, and F. Brombacher TH1-Dominant Granulomatous Pathology Does Not Inhibit Fibrosis or Cause Lethality during Murine Schistosomiasis Am. J. Pathol., November 1, 2006; 169(5): 1701 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Mora, E. Torres-Gonzalez, M. Rojas, C. Corredor, J. Ritzenthaler, J. Xu, J. Roman, K. Brigham, and A. Stecenko Activation of Alveolar Macrophages via the Alternative Pathway in Herpesvirus-Induced Lung Fibrosis Am. J. Respir. Cell Mol. Biol., October 1, 2006; 35(4): 466 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Nair, K. J. Guild, and D. Artis Novel Effector Molecules in Type 2 Inflammation: Lessons Drawn from Helminth Infection and Allergy J. Immunol., August 1, 2006; 177(3): 1393 - 1399. [Full Text] [PDF] |
||||
![]() |
M. Ferlito, K. Irani, N. Faraday, and C. J. Lowenstein Nitric oxide inhibits exocytosis of cytolytic granules from lymphokine-activated killer cells PNAS, August 1, 2006; 103(31): 11689 - 11694. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Baumgart, F. Tompkins, J. Leng, and M. Hesse Naturally Occurring CD4+Foxp3+ Regulatory T Cells Are an Essential, IL-10-Independent Part of the Immunoregulatory Network in Schistosoma mansoni Egg-Induced Inflammation J. Immunol., May 1, 2006; 176(9): 5374 - 5387. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Misson, S. van den Brule, V. Barbarin, D. Lison, and F. Huaux Markers of macrophage differentiation in experimental silicosis J. Leukoc. Biol., November 1, 2004; 76(5): 926 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hesse, C. A. Piccirillo, Y. Belkaid, J. Prufer, M. Mentink-Kane, M. Leusink, A. W. Cheever, E. M. Shevach, and T. A. Wynn The Pathogenesis of Schistosomiasis Is Controlled by Cooperating IL-10-Producing Innate Effector and Regulatory T Cells J. Immunol., March 1, 2004; 172(5): 3157 - 3166. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Chiaramonte, M. Mentink-Kane, B. A. Jacobson, A. W. Cheever, M. J. Whitters, M. E.P. Goad, A. Wong, M. Collins, D. D. Donaldson, M. J. Grusby, et al. Regulation and Function of the Interleukin 13 Receptor {alpha} 2 During a T Helper Cell Type 2-dominant Immune Response J. Exp. Med., March 17, 2003; 197(6): 687 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. MacDonald, M. I. Araujo, and E. J. Pearce Immunology of Parasitic Helminth Infections Infect. Immun., February 1, 2002; 70(2): 427 - 433. [Full Text] [PDF] |
||||
![]() |
A. C. La Flamme, E. A. Patton, and E. J. Pearce Role of Gamma Interferon in the Pathogenesis of Severe Schistosomiasis in Interleukin-4-Deficient Mice Infect. Immun., December 1, 2001; 69(12): 7445 - 7452. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hesse, M. Modolell, A. C. La Flamme, M. Schito, J. M. Fuentes, A. W. Cheever, E. J. Pearce, and T. A. Wynn Differential Regulation of Nitric Oxide Synthase-2 and Arginase-1 by Type 1/Type 2 Cytokines In Vivo: Granulomatous Pathology Is Shaped by the Pattern of L-Arginine Metabolism J. Immunol., December 1, 2001; 167(11): 6533 - 6544. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Park, K. F. Hoffmann, A. W. Cheever, D. Amichay, T. A. Wynn, and J. M. Farber Patterns of Chemokine Expression in Models of Schistosoma mansoni Inflammation and Infection Reveal Relationships between Type 1 and Type 2 Responses and Chemokines In Vivo Infect. Immun., November 1, 2001; 69(11): 6755 - 6768. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S.-H. Liu, M.-L. Zhao, C. F. Brosnan, and S. C. Lee Expression of Inducible Nitric Oxide Synthase and Nitrotyrosine in Multiple Sclerosis Lesions Am. J. Pathol., June 1, 2001; 158(6): 2057 - 2066. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Agostini, F. Calabrese, F. Rea, M. Facco, A. Tosoni, M. Loy, G. Binotto, M. Valente, L. Trentin, and G. Semenzato CXCR3 and Its Ligand CXCL10 Are Expressed by Inflammatory Cells Infiltrating Lung Allografts and Mediate Chemotaxis of T Cells at Sites of Rejection Am. J. Pathol., May 1, 2001; 158(5): 1703 - 1711. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |